Arcus Biosciences IncNYSE:RCUS
- LAST PRICE15.5600
- TODAY'S CHANGE (%)0.0600 (0.3871%)
- Bid / Lots15.1300/ 3
- Ask / Lots15.9800/ 2
- Open / Previous Close15.2400 / 15.5000
- Day Range
- 52 Week Range
- Volume590,487
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RCUS |
|---|---|---|
| 09:32 ET | 3024 | 15.24 |
| 09:33 ET | 500 | 15.47 |
| 09:35 ET | 300 | 15.46 |
| 09:37 ET | 2786 | 15.3 |
| 09:39 ET | 1571 | 15.24 |
| 09:42 ET | 439 | 15.15 |
| 09:44 ET | 13586 | 15.155 |
| 09:48 ET | 1770 | 15.31 |
| 09:50 ET | 1370 | 15.29 |
| 09:51 ET | 360 | 15.29 |
| 09:53 ET | 679 | 15.31 |
| 09:55 ET | 819 | 15.35 |
| 09:57 ET | 110 | 15.39 |
| 10:02 ET | 100 | 15.45 |
| 10:04 ET | 1000 | 15.47 |
| 10:08 ET | 822 | 15.45 |
| 10:09 ET | 421 | 15.49 |
| 10:13 ET | 354 | 15.485 |
| 10:15 ET | 208 | 15.45 |
| 10:20 ET | 200 | 15.45 |
| 10:22 ET | 290 | 15.5 |
| 10:24 ET | 100 | 15.56 |
| 10:26 ET | 200 | 15.56 |
| 10:27 ET | 854 | 15.565 |
| 10:29 ET | 433 | 15.585 |
| 10:31 ET | 400 | 15.55 |
| 10:33 ET | 2029 | 15.605 |
| 10:40 ET | 800 | 15.63 |
| 10:42 ET | 100 | 15.62 |
| 10:45 ET | 581 | 15.665 |
| 10:47 ET | 384 | 15.66 |
| 10:51 ET | 100 | 15.705 |
| 10:58 ET | 300 | 15.6915 |
| 11:00 ET | 1439 | 15.69 |
| 11:02 ET | 100 | 15.68 |
| 11:03 ET | 300 | 15.66 |
| 11:05 ET | 1202 | 15.61 |
| 11:07 ET | 300 | 15.6 |
| 11:09 ET | 200 | 15.63 |
| 11:12 ET | 500 | 15.6 |
| 11:14 ET | 1317 | 15.725 |
| 11:16 ET | 1416 | 15.755 |
| 11:20 ET | 100 | 15.77 |
| 11:21 ET | 200 | 15.68 |
| 11:23 ET | 300 | 15.67 |
| 11:25 ET | 200 | 15.67 |
| 11:27 ET | 830 | 15.685 |
| 11:30 ET | 2587 | 15.65 |
| 11:32 ET | 807 | 15.64 |
| 11:34 ET | 200 | 15.635 |
| 11:36 ET | 200 | 15.61 |
| 11:38 ET | 300 | 15.63 |
| 11:39 ET | 100 | 15.61 |
| 11:41 ET | 300 | 15.6 |
| 11:43 ET | 401 | 15.61 |
| 11:45 ET | 500 | 15.61 |
| 11:52 ET | 100 | 15.59 |
| 11:54 ET | 410 | 15.575 |
| 11:56 ET | 14942 | 15.645 |
| 11:57 ET | 700 | 15.735 |
| 11:59 ET | 250 | 15.745 |
| 12:01 ET | 625 | 15.78 |
| 12:03 ET | 867 | 15.78 |
| 12:06 ET | 500 | 15.795 |
| 12:08 ET | 100 | 15.83 |
| 12:12 ET | 100 | 15.795 |
| 12:14 ET | 100 | 15.79 |
| 12:15 ET | 1469 | 15.87 |
| 12:17 ET | 250 | 15.88 |
| 12:19 ET | 101 | 15.84 |
| 12:21 ET | 300 | 15.83 |
| 12:24 ET | 400 | 15.84 |
| 12:26 ET | 501 | 15.87 |
| 12:28 ET | 1469 | 15.865 |
| 12:32 ET | 1011 | 15.91 |
| 12:33 ET | 2206 | 15.88 |
| 12:35 ET | 1735 | 15.87 |
| 12:37 ET | 1708 | 15.88 |
| 12:39 ET | 344 | 15.8601 |
| 12:42 ET | 200 | 15.86 |
| 12:44 ET | 700 | 15.83 |
| 12:46 ET | 2194 | 15.86 |
| 12:48 ET | 100 | 15.85 |
| 12:50 ET | 1946 | 15.855 |
| 12:51 ET | 100 | 15.86 |
| 12:53 ET | 1371 | 15.91 |
| 12:55 ET | 100 | 15.93 |
| 12:57 ET | 300 | 15.915 |
| 01:00 ET | 1407 | 15.94 |
| 01:02 ET | 594 | 15.95 |
| 01:04 ET | 1187 | 15.94 |
| 01:06 ET | 1180 | 15.96 |
| 01:08 ET | 1195 | 15.94 |
| 01:09 ET | 940 | 15.921 |
| 01:11 ET | 200 | 15.915 |
| 01:13 ET | 100 | 15.89 |
| 01:15 ET | 500 | 15.89 |
| 01:18 ET | 100 | 15.88 |
| 01:22 ET | 300 | 15.87 |
| 01:24 ET | 400 | 15.88 |
| 01:26 ET | 614 | 15.9 |
| 01:27 ET | 942 | 15.91 |
| 01:31 ET | 500 | 15.9 |
| 01:33 ET | 300 | 15.9 |
| 01:36 ET | 1727 | 15.89 |
| 01:38 ET | 1536 | 15.905 |
| 01:40 ET | 1832 | 15.96 |
| 01:42 ET | 200 | 15.995 |
| 01:44 ET | 200 | 15.965 |
| 01:45 ET | 645 | 15.96 |
| 01:47 ET | 200 | 15.94 |
| 01:49 ET | 200 | 15.93 |
| 01:51 ET | 500 | 15.95 |
| 01:54 ET | 600 | 15.93 |
| 01:56 ET | 1237 | 15.93 |
| 01:58 ET | 300 | 15.92 |
| 02:00 ET | 1020 | 15.89 |
| 02:02 ET | 100 | 15.87 |
| 02:03 ET | 300 | 15.85 |
| 02:05 ET | 300 | 15.83 |
| 02:07 ET | 400 | 15.83 |
| 02:09 ET | 900 | 15.83 |
| 02:12 ET | 300 | 15.83 |
| 02:14 ET | 902 | 15.865 |
| 02:16 ET | 100 | 15.87 |
| 02:18 ET | 100 | 15.84 |
| 02:20 ET | 200 | 15.84 |
| 02:21 ET | 802 | 15.85 |
| 02:23 ET | 1535 | 15.88 |
| 02:25 ET | 400 | 15.89 |
| 02:27 ET | 100 | 15.87 |
| 02:30 ET | 200 | 15.86 |
| 02:32 ET | 2056 | 15.8 |
| 02:34 ET | 3711 | 15.75 |
| 02:36 ET | 200 | 15.765 |
| 02:38 ET | 650 | 15.755 |
| 02:39 ET | 535 | 15.72 |
| 02:41 ET | 600 | 15.71 |
| 02:43 ET | 1300 | 15.71 |
| 02:45 ET | 600 | 15.71 |
| 02:48 ET | 600 | 15.71 |
| 02:50 ET | 1380 | 15.725 |
| 02:52 ET | 5294 | 15.71 |
| 02:54 ET | 5529 | 15.705 |
| 02:56 ET | 1190 | 15.74 |
| 02:57 ET | 699 | 15.79 |
| 02:59 ET | 400 | 15.78 |
| 03:01 ET | 5463 | 15.815 |
| 03:03 ET | 200 | 15.815 |
| 03:06 ET | 5517 | 15.765 |
| 03:08 ET | 2976 | 15.71 |
| 03:10 ET | 3700 | 15.72 |
| 03:12 ET | 5200 | 15.685 |
| 03:14 ET | 1929 | 15.65 |
| 03:15 ET | 4777 | 15.75 |
| 03:17 ET | 2024 | 15.71 |
| 03:19 ET | 1387 | 15.75 |
| 03:21 ET | 100 | 15.75 |
| 03:24 ET | 200 | 15.745 |
| 03:26 ET | 3685 | 15.765 |
| 03:28 ET | 1026 | 15.785 |
| 03:30 ET | 900 | 15.785 |
| 03:32 ET | 2167 | 15.72 |
| 03:33 ET | 5748 | 15.74 |
| 03:35 ET | 1207 | 15.71 |
| 03:37 ET | 1800 | 15.64 |
| 03:39 ET | 2023 | 15.63 |
| 03:42 ET | 2146 | 15.63 |
| 03:44 ET | 5917 | 15.67 |
| 03:46 ET | 2890 | 15.6288 |
| 03:48 ET | 7377 | 15.565 |
| 03:50 ET | 5340 | 15.58 |
| 03:51 ET | 9184 | 15.63 |
| 03:53 ET | 5875 | 15.59 |
| 03:55 ET | 5614 | 15.58 |
| 03:57 ET | 22138 | 15.555 |
| 04:00 ET | 170891 | 15.56 |
Oct 30, 2024
Oct 25, 2024
DJ Arcus Biosciences Is Maintained at Overweight by Barclays, from 1:42PM ET on Friday Oct 25, 2024 by Dow Jones
1:42PM ET on Friday Oct 25, 2024 by Dow Jones
Oct 24, 2024
Arcus Biosciences Announces New Employment Inducement Grants, from 4:35PM ET on Thursday Oct 24, 2024 by Dow Jones
4:35PM ET on Thursday Oct 24, 2024 by Dow JonesDJ Arcus Biosciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 3:31PM ET on Thursday Oct 24, 2024 by Dow Jones
3:31PM ET on Thursday Oct 24, 2024 by Dow JonesDJ Arcus Biosciences Shares Rise After Kidney Cancer Drug Shows Promise in Early-Stage Trial, from 8:19AM ET on Thursday Oct 24, 2024 by Dow Jones
8:19AM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
Ardelyx Inc | 1.4B | -18.9x | --- |
Gyre Therapeutics Inc | 1.4B | -17.1x | --- |
Travere Therapeutics Inc | 1.4B | -4.0x | --- |
Vir Biotechnology Inc | 1.3B | -2.4x | --- |
Immatics NV | 1.3B | -10.4x | --- |
Company Information
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Contact Information
- Headquarters
- 3928 Point Eden WayHAYWARD, CA, United States 94545-3719
- Phone
- 510-694-6200
- Fax
- 302-730-1370
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Terry Rosen
- President, Co-Founder
- Juan Jaen
- Chief Financial Officer
- Robert Goeltz
- Chief Operating Officer
- Jennifer Jarrett
- General Counsel
- Carolyn Tang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
